I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Denham, Douglas
56
results:
Search for persons
X
Format
Online (56)
Mediatypes
Articles (Online) (31)
Bookchapter (Online) (1)
OpenAccess-fulltext (24)
Sorted by: Relevance
Sorted by: Year
?
1
Immunogenicity, efficacy, and safety of biosimilar insulin ..:
Christofides, Elena A.
;
Puente, Orlando
;
Norwood, Paul
...
Diabetes, Obesity and Metabolism. 26 (2024) 6 - p. 2412-2421 , 2024
Link:
https://doi.org/10.1111/..
?
2
Immunogenicity, Efficacy, and Safety of Biosimilar Insulin ..:
Christofides, Elena A.
;
Stankiewicz, Andrzej
;
Denham, Douglas
...
Endocrine Practice. , 2024
Link:
https://doi.org/10.1016/..
?
3
Long-Term Safety and Efficacy of Recombinant Human Parathyr..:
Watts, Nelson B
;
Bilezikian, John P
;
Bone, Henry G
...
Journal of the Endocrine Society. 7 (2023) 5 - p. , 2023
Link:
https://doi.org/10.1210/..
?
4
EDP-305 in patients with NASH: A phase II double-blind plac..:
Ratziu, Vlad
;
Rinella, Mary E.
;
Neuschwander-Tetri, Brent A.
...
Journal of Hepatology. 76 (2022) 3 - p. 506-517 , 2022
Link:
https://doi.org/10.1016/..
?
5
TERN-101, a farnesoid X receptor agonist, demonstrated simi..:
Lawitz, Eric
;
Loomba, Rohit
;
Denham, Douglas
...
Journal of Hepatology. 77 (2022) - p. S715-S716 , 2022
Link:
https://doi.org/10.1016/..
?
6
Favorable safety profile of TERN-201, a highly selective in..:
Noureddin, Mazen
;
Lawitz, Eric
;
Alkhouri, Naim
...
Journal of Hepatology. 77 (2022) - p. S731-S732 , 2022
Link:
https://doi.org/10.1016/..
?
7
A Head-to-Head Comparison Study of the First-Day Performanc..:
Denham, Douglas
Journal of Diabetes Science and Technology. 14 (2020) 2 - p. 493-495 , 2020
Link:
https://doi.org/10.1177/..
?
8
Effect of Repeated Doses of Acetaminophen on a Continuous G..:
Denham, Douglas
Journal of Diabetes Science and Technology. 15 (2020) 2 - p. 517-518 , 2020
Link:
https://doi.org/10.1177/..
?
9
EDP-305, a non-bile acid farnesoid X receptor (FXR) agonist..:
Ratziu, Vlad
;
Rinella, Mary
;
Tetri, Brent
...
Journal of Hepatology. 73 (2020) - p. S56-S57 , 2020
Link:
https://doi.org/10.1016/..
?
10
Safety and Efficacy of 5 Years of Treatment With Recombinan..:
Mannstadt, Michael
;
Clarke, Bart L
;
Bilezikian, John P
...
The Journal of Clinical Endocrinology & Metabolism. 104 (2019) 11 - p. 5136-5147 , 2019
Link:
https://doi.org/10.1210/..
?
11
OR30-1 Safety and Efficacy of Recombinant Human Parathyroid..:
Bilezikian, John
;
Bone, Henry
;
Clarke, Bart
...
Journal of the Endocrine Society. 3 (2019) Supplement_1 - p. , 2019
Link:
https://doi.org/10.1210/..
?
12
Publisher Correction: Glucagon receptor antagonist volagide..:
Pettus, Jeremy
;
Boeder, Schafer C.
;
Christiansen, Mark P.
...
Nature Medicine. 29 (2023) 11 - p. 2959-2959 , 2023
Link:
https://doi.org/10.1038/..
?
13
Glucagon receptor antagonist volagidemab in type 1 diabetes..:
Pettus, Jeremy
;
Boeder, Schafer C.
;
Christiansen, Mark P.
...
Nature Medicine. 28 (2022) 10 - p. 2092-2099 , 2022
Link:
https://doi.org/10.1038/..
?
14
Glycemic Effect and Safety of a Systemic, Partial Glucokina..:
Denney, William S.
;
Denham, Douglas S.
;
Riggs, Michael R.
.
Clinical Pharmacology in Drug Development. 5 (2016) 6 - p. 517-527 , 2016
Link:
https://doi.org/10.1002/..
?
15
Metanx in Type 2 Diabetes with Peripheral Neuropathy: A Ran..:
Fonseca, Vivian A.
;
Lavery, Lawrence A.
;
Thethi, Tina K.
...
The American Journal of Medicine. 126 (2013) 2 - p. 141-149 , 2013
Link:
https://doi.org/10.1016/..
1-15